Thomas Kieber-Emmons

Title: Thomas Kieber-Emmons: Innovator in Biologically Active Compounds

Introduction

Thomas Kieber-Emmons is a notable inventor based in Newtown Square, Pennsylvania. He has made significant contributions to the field of biologically active compounds, particularly in relation to HIV-1 Vpr protein. With a total of four patents to his name, Kieber-Emmons has focused on developing methods and compositions that enhance therapeutic delivery and inhibit cell proliferation.

Latest Patents

Kieber-Emmons' latest patents include innovative approaches to utilizing functional fragments of the HIV-1 Vpr protein. These patents disclose conjugated compositions that comprise a fragment of HIV-1 Vpr or a non-HIV-1 Vpr protein linked to therapeutic compounds. The methods outlined in these patents aim to deliver therapeutic compounds directly to a cell's nucleus or prepare drug delivery particles. Additionally, he has developed methods for inhibiting cell proliferation and treating individuals with hyperproliferative diseases. His work also includes identifying compounds that inhibit Vpr protein binding to specific domains, along with kits for performing these methods.

Career Highlights

Throughout his career, Kieber-Emmons has worked with prestigious institutions such as the University of Pennsylvania and The Wistar Institute. His research has significantly advanced the understanding of biologically active compounds and their applications in medicine.

Collaborations

Some of his notable coworkers include David B. Weiner and William Valentine Williams. Their collaborative efforts have contributed to the development of innovative solutions in the field of biologically active compounds.

Conclusion

Thomas Kieber-Emmons is a distinguished inventor whose work in biologically active compounds has the potential to impact therapeutic strategies significantly. His innovative patents and collaborations reflect his commitment to advancing medical science.